
[
  {
    "question": "The following descriptions about complement system which one is CORRECT?",
    "options": {
      "A": "The highest concentration of the complement component in the serum is C5, that is why the patients with deficiency of C5 have recurrent infections.",
      "B": "There are 3 pathways, classical, lectin and alternative pathway. These pathways differ in how C3 is produced but follow a common sequence after C5 cleavage.",
      "C": "In classical pathway, both antigen-bound and antigen-free antibody can bind and activate C1 component.",
      "D": "Activated C3a and C5a can covalently bind to the bacterial cell wall and initiate phagocytosis"
    },
    "answer": "B",
    "explanation": "（B）正確。\n（A）補體中以C3 為最多也最重要,若人體的 C3 有缺陷會使其益受到細菌感染。\n（C） 只有與抗原結合的抗體可以開啟古典途徑,用以避免不必要的免疫反應。\n（D）C3a與C5a發炎介質,可增加血管通透性,促使吞噬細胞移動至受感染區域,並促進吞噬作用。而會與細菌表面結合的為 C3b 與 C5b。\n［出處］共筆 Vol.1,單元2,P21~P30",
    "original_number": 1
  },
  {
    "question": "Antimicrobial peptides (AMP) are part of innate immunity. Which of the statement is CORRECT?",
    "options": {
      "A": "AMPs have a selectivity against bacterial but not host cells.",
      "B": "AMPs are part of mechanical barrier to prevent the entry of pathogens.",
      "C": "AMPs are amphipathic peptides that have a hydrophilic end and a hydrophobic end.",
      "D": "AMPs are only secreted by immune cells but not nonimmune cells."
    },
    "answer": "C",
    "explanation": "（C）正確。\n(A)AMP 不具專一性。\n(B)AMP 屬於化學屏障(chemical barrier)。\n(D)上皮細胞與吞噬細胞都會分泌 AMP。\n［出處］共筆 Vol.1,單元2,P17",
    "original_number": 2
  },
  {
    "question": "About phagocytosis, which is CORRECT?",
    "options": {
      "A": "The phagocytosis mechanism by neutrophil and macrophage is very different.",
      "B": "When antigen is phagocytosed by neutrophil and macrophage, the pH in the phagolysosomes of the cell will increase to digest the antigen.",
      "C": "Only macrophage but not neutrophil will secrets AMP when performing phagocytosis.",
      "D": "Only neutrophil but not macrophage will perform a special kind of apoptosis called NETosis, which releases its DNA to trap antigens."
    },
    "answer": "D",
    "explanation": "（D）正確。\n(A)吞噬作用的機制相似。\n(B)pH值應為下降。\n(C)巨噬細胞與嗜中性球皆會分泌AMP。\n［出處］共筆 Vol.1,單元3",
    "original_number": 3
  },
  {
    "question": "Pattern recognition receptors (PRR) are expressed on most innate immune cells that can recognize pathogen-associated molecular patterns (PAMPs). Which of following statement is NOT CORRECT?",
    "options": {
      "A": "TLR4 requires MD2 to facilitate the binding of LPS, a key component of gram-negative bacterial cell wall.",
      "B": "PRRs are expressed on different compartments of immune cells, including plasma membrane, cytosol, endosome and nucleus.",
      "C": "NLR (Nod-like receptor), CLR (C-type lectin receptor), RLR (Rig-I like receptor), TLR (Toll-like receptor) and CDS (Cytosolic DNA sensor) all belong to PRR.",
      "D": "The binding of PAMP to PRR usually results in production of cytokines, including IL-6, TNFα and type I interferon."
    },
    "answer": "B",
    "explanation": "（B）PRRs 分布的位置不含 nucleus\n［出處］共筆 Vol.1,單元3,P37",
    "original_number": 4
  },
  {
    "question": "In terms of antibody structure, which statement is CORRECT?",
    "options": {
      "A": "CDR1, 2, 3 both heavy chain and light chain determines the binding region structure with antigen.",
      "B": "(選項遺失)",
      "C": "The production of membrane bound or secreted form of IgM in a B cells is determined by DNA rearrangement.",
      "D": "(選項遺失)"
    },
    "answer": "A",
    "explanation": "（A）正確。\n(C)抗原結合位與 class switching 才是由 DNA rearrangement決定;而產生 IgM或 IgD 與產生分泌型或受體型的 IgM 則是由 RNA splicing 決定。\n［出處］共筆 Vol.2,單元7",
    "original_number": 5
  },
  {
    "question": "Monoclonal antibody (mAb) is important for treating diseases. Which statement concerning mAbs are CORRECT?",
    "options": {
      "A": "Traditional way to make mAbs is to fuse a naive B cell with a tumor B cell line.",
      "B": "There is no way to make an mAb against an antibody because they are the same.",
      "C": "Anti-CTLA-4 and Anti-PD-1 antibodies are two mAbs successfully used to treat cancer patients.",
      "D": "Trastuzumab is a fully human antibody."
    },
    "answer": "C",
    "explanation": "（C）正確。\n(A)應為融合腫瘤細胞與漿細胞。\n(D)單株抗體藥物命名規則如下:\n-omab:抗體全部來自老鼠基因。\n-ximab:抗體的恆定區來自人類基因,但抗原辨識位來自老鼠的基因。\n-zumab:抗體的抗原辨識位一部份(CDR1、2、3)來自老鼠的基因。\n-umab:抗體全部來自人類基因。\n［出處］共筆 Vol.2,單元7,P51~P56",
    "original_number": 6
  },
  {
    "question": "Presentation of pre-B receptor is an important checkpoint in B cell development. Which statement concerning signal from pre-B receptor is CORRECT?",
    "options": {
      "A": "Will inhibit light chain gene rearrangement",
      "B": "Will promote heavy chain gene rearrangement",
      "C": "Will promote surrogate light gene rearrangement",
      "D": "Will enhance pre-B cell proliferation"
    },
    "answer": "D",
    "explanation": "（D）正確。\n(A)促進輕鍊的基因重組\n(B)抑制重鍊的基因重組\n(C)抑制替代輕鍊的基因重組\n［出處］共筆 Vol.2,單元5",
    "original_number": 7
  },
  {
    "question": "Regarding ITAM and ITIM, which is NOT CORRECT?",
    "options": {
      "A": "Upon activation by tyrosine phosphorylation, ITAM recruits kinases to positively regulate immune response.",
      "B": "CTLA4 can negatively regulate T cell response by competing the binding of B7 with CD28 and simultaneously transduce negative signal.",
      "C": "T cell receptor (TCR) itself has 6 ITAMs in its intracellular domain to trigger signal events after engaging with MHC-peptide.",
      "D": "Immune checkpoint blockade for cancer treatment is using anti-CTLA-4 or anti-PD1 to inhibit the negative signals in T cells."
    },
    "answer": "C",
    "explanation": "（C）正確。\n(C)TCR有10個ITAM 在胞內區域\n［出處］共筆 Vol.1,單元4",
    "original_number": 8
  },
  {
    "question": "Post-transcriptional modification like tyrosine phosphorylation is important for many reactions. Which statement is NOT CORRECT?",
    "options": {
      "A": "Tyrosine on the receptor is phosphorylated for initiation.",
      "B": "Scaffold protein is phosphorylated to recruit downstream molecules.",
      "C": "When the phosphate is removed by protein tyrosine phosphatase, the signal will be terminated.",
      "D": "Non-tyrosine kinase receptors use intracellular kinase domain to phosphorylate its downstream molecules."
    },
    "answer": "D",
    "explanation": "（D） Non-tyrosine kinase receptors 胞內不具有 Kinase 的功能區,而是先吸引磷酸激酶前來與受體非共價結合,接著受體與配體結合後,受體會二聚化,兩個激酶因互相磷酸化而活化,繼而磷酸化下游受質。\n［出處］共筆 Vol.1,單元4",
    "original_number": 9
  },
  {
    "question": "Which one of the following signaling determines the commitment of T-cell lineage?",
    "options": {
      "A": "BCR",
      "B": "Notch",
      "C": "RAS",
      "D": "TCR",
      "E": "TLR"
    },
    "answer": "B",
    "explanation": "（B）正確。\n在T細胞發育中,Notch 訊號使前驅細胞發育為T細胞而非B細胞,且調節T細胞發育為α:β T細胞或γ:δ T細胞之間的選擇。\n［出處］共筆 Vol.2 p.19",
    "original_number": 1
  },
  {
    "question": "Mutant with MHC class I transgene that cannot interact with CD8:",
    "options": {
      "A": "Only CD4+ T",
      "B": "No CD4+ or CD8+ T",
      "C": "Only CD8+ T",
      "D": "Both CD4+ and CD8+ T"
    },
    "answer": "A",
    "explanation": "（A）正確。\nNo MHC Class I to interact with double positive T cells and therefore no CD8+ T cells will mature due to failed positive selection for CD8+ T cells.\n［出處］共筆 Vol.2 p.32",
    "original_number": 2
  },
  {
    "question": "Double-negative T cell with CD44+, CD25- markers:",
    "options": {
      "A": "DN1 T cell",
      "B": "DN2 T cell",
      "C": "DN3 T cell",
      "D": "DN4 T cell"
    },
    "answer": "A",
    "explanation": "（A）正確。\n［出處］共筆 Vol.2 p.21",
    "original_number": 3,
    "figure": "Rearrangement\nPro-T cell\nPre-T cell\nDouble-negative\nDouble-positive\nSingle-\npositive\nDN1\nDN2\nDN3\nDN4\nproliferation\npre-TCR\nCD4 CD8\nTCR\nCD44+\nCD25-\nCD44+ CD44low CD44-\nCD25+ CD25+\nCD25-"
  },
  {
    "question": "Which protein does not participate in RAG-dependent V(D)J Rearrangement?",
    "options": {
      "A": "Ku70",
      "B": "AID",
      "C": "TdT",
      "D": "Artemis",
      "E": "XRCC4"
    },
    "answer": "B",
    "explanation": "（B）正確。\nAID stands for activation-induced cytidine deaminase, which is involved in hypermutation, gene conversion, and class-switching。\n［出處］共筆 Vol.3 p.6",
    "original_number": 4
  },
  {
    "question": "When the two gene segments are in the same transcriptional orientation in the germ line DNA, their DNA rearrangement involves X and Y of the DNA between them?",
    "options": {
      "A": "inversion and deletion",
      "B": "inversion and integration",
      "C": "looping-out and deletion",
      "D": "looping-out and integration"
    },
    "answer": "C",
    "explanation": "（C）正確。\nOpposite transcription orientation leads to inversion and integration。\n［出處］共筆 Vol.3 p.5",
    "original_number": 5
  },
  {
    "question": "The exogenous pathway of loading peptide/antigen onto MHC class 1 is called cross-presentation and is actively practiced by X.",
    "options": {
      "A": "B cell",
      "B": "Dendritic cell",
      "C": "Hepatocyte cell",
      "D": "Macrophage",
      "E": "NK cell"
    },
    "answer": "B",
    "explanation": "（B）正確。\nCross-presentation is actively practiced by dendritic cell。\n［出處］共筆 Vol.3,單元9",
    "original_number": 6
  },
  {
    "question": "Which feature of class I molecules is not correct?",
    "options": {
      "A": "Accommodate peptide of 8-11 residues",
      "B": "CD8 mainly binds to alpha 3 domain",
      "C": "Location of polymorphic are alpha 1 & 2 domain",
      "D": "Nomenclature are HLA-A/B/C in human",
      "E": "Polypeptide chains are Alpha and beta"
    },
    "answer": "E",
    "explanation": "（E）錯誤。\nShould be alpha and beta2-microglobulin.\n［出處］共筆 Vol.3,單元9",
    "original_number": 7
  },
  {
    "question": "下列關於 Class I MHC pathway 中的抗原處理與呈現,何者不正確？(原題目為英文)",
    "options": {
      "A": "所有有核的細胞都是 APC",
      "B": "CD8+ T cell is type of responsive T cell",
      "C": "ER 是 peptide load 到 MHC 上的地方",
      "D": "TAP-1/2參與了 peptide 的裝載與呈現"
    },
    "answer": "D",
    "explanation": "（D）錯誤。\nTAP is involved with peptide loading but not antigen presentation.\n［出處］共筆 Vol.3,單元 10",
    "original_number": 8
  },
  {
    "question": "Which of the following proteins is not a component of the peptide loading complex (PLC)?",
    "options": {
      "A": "Calreticulin",
      "B": "ERp57",
      "C": "LMP7",
      "D": "TAP",
      "E": "Tapasin"
    },
    "answer": "D",
    "explanation": "（D）錯誤。\nLMP7 is an immunoproteasome. It degrades foreign peptides for subsequent loading and presentation of antigens。\n［出處］共筆 Vol.3,單元 10",
    "original_number": 9
  },
  {
    "question": "About superantigen, which is false?",
    "options": {
      "A": "Binds MHC class II.",
      "B": "Does not bind to the conventional peptide binding groove.",
      "C": "Bacterial superantigens bind mainly to the Vb CDR2 loop.",
      "D": "Viral superantigens bind mainly to the hypervariable 2 (HV2) loop.",
      "E": "Toxic shock syndrome toxin-1 (TSST-1) is a bacterial superantigen."
    },
    "answer": "D",
    "explanation": "（D）錯誤。\nNo MHC Class I to interact with double positive T cells and therefore no CD8+ T cells will mature due to failed positive selection for CD8+ T cells. (A) 可以同時和 TCR 及 MHC II 結合並活化 T細胞。(B) 和 TCR 結合位置在側面,非抗原結合位。(D) 病毒的 superantigen 主要和 TCR 的HV4 loop 結合。\n［出處］共筆 Vol.3,單元10,p.32",
    "original_number": 10
  },
  {
    "question": "cytokine induce IgA?",
    "options": {
      "A": "IF-12",
      "B": "IL-4",
      "C": "TNF-α",
      "D": "TGF-β",
      "E": "IFN-γ"
    },
    "answer": "D",
    "explanation": "（D）正確。\n［出處］共筆 Vol.3,單元11,p.48",
    "original_number": 11,
    "figure": "Role of cytokines in regulating expression of antibody classes\nCytokines IgM\nIgG3\nIgG1\nIgG2b\nIgG2a\nIgE\nIgA\nIL-4\nInhibits\nInhibits\nInduces\nInhibits\nInduces\nIL-5\nAugments\nproduction\nIFN-γ\nInhibits\nInduces\nInhibits\nInduces\nInhibits\nTGF-β\nInhibits\nInhibits\nInduces\nInduces\nIL-21\nInduces Induces\nInduces"
  },
  {
    "question": "Which kind of cell expresses FcɛRI?",
    "options": {
      "A": "Neutrophil",
      "B": "Basophil",
      "C": "Macrophage",
      "D": "B cell",
      "E": "NK cell"
    },
    "answer": "B",
    "explanation": "（B）正確。\n［出處］共筆 Vol.4,單元11,p.1",
    "original_number": 12,
    "figure": "Receptor\nFcyRI\n(CD64)\nFcyRII-A FcyRII-B2 FcyRII-B1\n(CD32)\n(CD32) (CD32)\nFcyRIII\n(CD16)\nFcεRI\nFcεRII\n(CD23)\nFcaRl\n(CD89)\nFca/µR\na 72 kDa\na 40 kDa\nStructure\nα 50-70 kDa\na 45 kDa\nlectin trimer\ndomain\n7\nγοιζ\nβ 33 kDa\n1079 kDa\nα 55-75 kDa\n8.\ny 9 kDa\na 70 kDa\n0\nH\nN\ny-like\ndomain\nITIM\nIgG1\nBinding\nIgG1\nIgG1\nITIM\nIgG1\n108 M-1\n2x 106 M-1\n2x 106M-1\n2 x 106M-1\nOrder of\n1) IgG1=lgG3\n1) IgG1\n1) IgG1=IgG3\naffinity\n2) IgG4\n2) IgG3-IgG2*\n2) IgG4\n1) IgG1-IgG3\n2) IgG4\nIgG1\n5 x 105 M-1\nIgG1-IgG3\nIgE\n1010 M-1\nIgE\nIgA1, IgA2\n2-7 x 107 M1 107 M-1\n(trimer)\nIgA, IgM\n3 x 109 M-1\nIgA1=IgA2\n3) IgG2\n3) IgG4\n3) IgG2\n3) IgG2\n2-7 x 106 M-1\n(monomer)\n1) IgM\n2) IgA\nCell type\nMacrophages Macrophages Macrophages\nNeutrophils Neutrophils Neutrophils\nEosinophils Eosinophils Eosinophils\nPlatelets\nLangerhans\ncells\nB cells\nMast cells\nNK cells\nEosinophils\nMacrophages\nNeutrophils\nMast cells\nBasophils\nEosinophils\nB cells\nMacrophages\nEosinophilst\nNeutrophils\nMacrophages\nB cells\nMast cells\nEffect of\nligation\nUptake\nStimulation\nActivation of\nUptake\nGranule\nrelease\nUptake\nInhibition\nof\nNo uptake\nInhibition\nof\nInduction\nof killing\n(NK cells)\nSecretion\nof granules\nDegranulation\nUptake\nInduction of\nkilling\nUptake\nrespiratory burst (eosinophils) stimulation stimulation\nInduction\nof killing"
  },
  {
    "question": "CD4+T可促進APC表現X及B7,以活化 CD8+T,請問X為下列何者?(原題目為英文)",
    "options": {
      "A": "4-1BBL",
      "B": "CD28",
      "C": "CTLA-4",
      "D": "PD-1",
      "E": "TIM-3"
    },
    "answer": "A",
    "explanation": "（A）正確。\nCD4+T細胞利用 CD40L(CD40 ligand)反送訊號給抗原呈現細胞促進其共同刺激分子(B7、4-1BBL)的表現,4-1BBL(4-1BB ligand)和 CD8+T 細胞膜上的4-1BB 結合並活化 CD8+T細胞。\n［出處］共筆 Vol.4,單元13,p.28",
    "original_number": 13
  },
  {
    "question": "Which of the following cell-surface molecules is not expressed in activated T-cell?",
    "options": {
      "A": "CD44",
      "B": "CD45RO",
      "C": "VLA-4",
      "D": "L-selectin",
      "E": "PSLG-1"
    },
    "answer": "D",
    "explanation": "（D）正確。\n初始T細胞在 Resting state 表現 L-selectin,活化後則不表現。\n［出處］共筆 Vol.4 P.22",
    "original_number": 14,
    "figure": "Cell-surface molecules\nT-cell\nCD4 T cell\nL-selectin PSLG-1 S1PR1 CD45RA CD45R0\nVLA-4\nCD4\nLFA-1\nCD2\nCD44\nreceptor\nResting\nActivated\n+\n+\n+\n+\n+\n+\n+\n+\n+\n+\n+\n++\n++\n++"
  },
  {
    "question": "STAT6 is mainly expressed in which subset of CD4+ T cell?",
    "options": {
      "A": "$T_{H}1$",
      "B": "$T_{H}2$",
      "C": "$T_{H}17$",
      "D": "$T_{FH}$",
      "E": "$T_{reg}$"
    },
    "answer": "B",
    "explanation": "（B）正確。\nIL-4會活化轉錄因子 STAT6,生成 $T_{H}2$。\n［出處］共筆 Vol.4 P.24",
    "original_number": 15,
    "figure": "IFN-γ IL-12\nIL-4\nIL-6\nIL-23\nIL-6\nIL-2\nSTAT1 STAT4\nSTAT6\nSTAT3\nSTAT3\nSTAT5\nT-bet\nGATA-3\nRORγT\nBcl-6\nFoxP3\nTH1\nTH2\nTH17\nTFH\nTreg"
  },
  {
    "question": "What kind of cytokine can be secreted by pDC?",
    "options": {
      "A": "IL-4",
      "B": "IL-17",
      "C": "IFN-α",
      "D": "IFN-γ",
      "E": "TGF-β"
    },
    "answer": "C",
    "explanation": "（C）正確。\n漿細胞樣樹突細胞 (pDC,plasmacytoid dendritic cell) 能產生大量第一型干擾素(IFN-α、IFN-β),其中,IFN-α 主要由 pDC 產生。\n［出處］共筆 Vol.4 P.14",
    "original_number": 16
  },
  {
    "question": "Which one of the following microbes is the target of TH2 cells?",
    "options": {
      "A": "Candida spp",
      "B": "Listeria spp",
      "C": "Klebsiella spp",
      "D": "Mycobacterium spp",
      "E": "Parasites"
    },
    "answer": "E",
    "explanation": "（E）正確。\n$T_{H}2$ 主要對付蠕蟲、寄生蟲 (Type II immunity)。\n［出處］共筆 Vol.4 P.26-27",
    "original_number": 17,
    "figure": "Major\ncytokines\nand their\nactions\nCD4 T cells: peptide + MHC class II\nTH1 cells\nTH2 cells\nTH17 cells\nTFH cells\nTreg cells\nTH1\nTH2\nTH17\nTH\nTreg\ninhibit\nIFN-Y\nIL-4, IL-5\nIL-13\nIL-17\nIL-22\nIL-21\nmucus\nmacrophage\nintra-\ncellular\nbacteria\nImmune\ncell types\ntargeted for\nenhanced\nrecruitment/\nfunction\ndead intracellular bacteria\nbone\nmarrow\ngoblet\ncell\nstromal epithelial\ncells\ncells\nG-CSF, antimicrobial\nchemokines peptides\neosinophil\nmast\ncell\nbasophil\nMicrobes\ntargeted\nMicrobes that persist\nin macrophage\nvesicles (e.g.,\nHelminth\nparasites\nmycobacteria, Listeria,\nLeishmania donovani,\nPneumocystis carinii)\nExtracellular bacteria\ncel\nIgM\ndendritic cell\nIgG\nB cell\nCD4\nJa\nplasma\ncell\nneutrophils\nisotype switching,\naffinity maturation\nlack of\nT-cell activation\nAll types\nExtracellular bacteria\n(e.g., Klebsiella\npneumoniae)\nFungi\n(Candida albicans)"
  },
  {
    "question": "Herd immunity is best described as",
    "options": {
      "A": "Vaccination of livestock herd",
      "B": "Protecting individuals who have not been vaccinated",
      "C": "Vaccinating the contacts of an infected person",
      "D": "Using multiple vaccines at one time",
      "E": "Protection of vaccinated individuals"
    },
    "answer": "B",
    "explanation": "（B）正確。\n(B) 群體免疫指在一群體中若有足夠的人對病原體有免疫力,便能有效阻斷病原體在該群體內的傳播,使群體中沒有免疫力的(未接種的)人間接獲得了保護\n［出處］共筆 Vol.5,單元 17",
    "original_number": 1
  },
  {
    "question": "Which of the following is wrong?",
    "options": {
      "A": "Using immunosuppressive drugs may cause increase the risk of infection",
      "B": "CAR-T include extracellular domain, transmembrane domain, and an intercellular signaling domain",
      "C": "Antibody can be engineered to increase immunogenicity by humanization",
      "D": "Tumor cells may be eliminated by the immune system, but as they evolve, variants occur and eventually escape immune surveillance and form tumor",
      "E": "HPV vaccine can prevent cervical cancer"
    },
    "answer": "C",
    "explanation": "（C）錯誤。\n(C) increase 應改為 decrease,抗體人類化能降低單株抗體的免疫原性,避免其受人體免疫系統攻擊而失去療效。\n(A)(B)(D) 皆正確\n［出處］共筆 Vol.5,單元 18",
    "original_number": 5
  },
  {
    "question": "About transplantation, which one is incorrect?",
    "options": {
      "A": "Thanks to immunosuppressive drug, MHC matching is no longer the major problem of transplantation.",
      "B": "Skin graft is B-cell mediated.",
      "C": "Major histocompatibility antigen matching is important.",
      "D": "Minor histocompatibility antigen matching is also important, too."
    },
    "answer": "B",
    "explanation": "（B）錯誤。\n(B) 皮膚移植的排斥反應為 T-cell mediated 的免疫反應\n(A)(C)(D) 皆正確\n［出處］共筆 Vol.6,單元20",
    "original_number": 6
  },
  {
    "question": "All of the following are tenets of the hygiene hypothesis except",
    "options": {
      "A": "childhood exposure to microorganisms is increased.",
      "B": "widespread use of antibiotics interferes with the use and education of the immune system..",
      "C": "widespread immunization practices compromise the development of a fully functional immune response.",
      "D": "an increase in allergic disease in developed countries compared to developing countries.",
      "E": "antibiotic-driven selection of super bacteria perturbs the immune system."
    },
    "answer": "A",
    "explanation": "（A）錯誤。\n(A)應改為”reduced”。\n(B)(C)(D)(E) 皆正確,可參考下表(截圖自老師 ppt)。\n［出處］共筆 Vol.6,單元20",
    "original_number": 7,
    "figure": "Tenets of the hygiene hypothesis\nExcessive hygiene reduces childhood exposure\nto commensal and pathogenic microorganisms\nas well as to other humans and to animals.\nVaccination reduces the developing immune\nsystem's experience in facing natural infections,\nfighting them to a successful conclusion and\nterminating them.\nOverreliance on antibiotics to terminate infections\nreduces the use of the immune system and its\neducation in the discrimination of self from\nforeign pathogenic microorganisms.\nAntibiotics also select for resistant superbacteria,\nwhich also perturb the immune system."
  },
  {
    "question": "Which of the following molecule(s) can transduce inhibitory signal to T cells? (select ALL that apply)",
    "options": {
      "A": "CD3",
      "B": "CD28",
      "C": "PD-1",
      "D": "4-1BB",
      "E": "B7",
      "F": "CTLA-4",
      "G": "CD25",
      "H": "CD20"
    },
    "answer": ["C", "F", "G"],
    "explanation": "(c)(e)(f),見08共筆 Vol.3 p.31 的圖、Vol.4 p.15、p.22、Vol.5 p32。\n(a) CD3 是活化T細胞的 co-receptor。\n(b) CD28 是活化T細胞的 receptor,接受costimulator,屬於 signal2。\n(d) 41BB是活化T細胞的 receptor,和costimulator 41BBL結合。\n(f) 皆為抑制T細胞活性的 receptor,即2018 年諾貝爾生理醫學獎。\n［出處］跨章節整合題",
    "original_number": 9
  },
  {
    "question": "Type I immunity: \nType II immunity: \nType III immunity:",
    "options": {
      "Cells": "ILC1、ILC2、ILC3、$T_{H}1$、$T_{H}2$、$T_{H} 17$",
      "Cytokines": "IL-5、IFN gamma 、TNF alpha、IL-4、IL-17、IL-22、IL-13"
    },
    "answer": "NA",
    "explanation": "請參見上課簡報及共筆中的統整表格:\nInnate lymphoid cells (ILCs)\nGroup 1 ILCs\nGroup 2 ILCS\nintracellular bacteria\nviruses\nhelminths\nIL-12\n000\nepithelial\nOcells\nTSLP IL-33 IL-25\nILC1\nNK\nILC2\nIFN-y\nIFN-Y\n▼\nIL-13\nIL-5\nFigure 11.3 Janeway's Immunobiology, 9th ed. ( Garland Science 2017)\nType 1 Immunity\nType 2 Immunity\nGroup 3 ILCS\nextracellular bacteria\nIL-23\nILC3\n▼\nIL-17\nIL-22\nType 3 Immunity\nThe major categories of innate lymphoid cells (ILCs) and their properties\nInnate lymphoid subgroup\nInducing cytokine\nEffector molecules produced\nFunction\nNK cells\nIL-12\nIFN-y, perforin, granzyme\nImmunity against viruses, intracellular pathogens\nILC1\nIL-12\nIFN-γ TNFa\nDefense against viruses, intracellular pathogens\nILC2\nIL-25, IL-33, TSLP\nIL-5, IL-13 IL-4\nExpulsion of extracellular parasites\nILC3, LTI cells\nIL-23\nIL-22, IL-17\nImmunity to extracellular bacteria and fungi\nFigure 3.37 Janeway's Immunobiology, 9th ed. ( Garland Science 2017)\n［出處］跨章節整合題",
    "original_number": 1
  },
  {
    "question": "Anaphylactic shock\nType 1 hypersensitivity\nTuberculin test\nWheal and flare response",
    "options": {
      "A": "Involves mast cell, basophil, and eosinophil",
      "B": "IgE mediated hypersensitivity",
      "C": "Has immediate and late response",
      "D": "Type IV hypersensitivity"
    },
    "answer": "NA",
    "explanation": "Differentiation/activation\nof ILC subsets\nImmune effector modules\nType 1\nILC1, Th1, IgG1/2,Mφ\nCD40L\nNK\nE4BP4+\nIFN-γ\nIFN-Y\nmacrophage\nIL-7 IL-12 IL-15\nILC1\nT-bet\nDifferentiation/activation\nof effector T-cell subsets\nMHC I:\npeptide\nCTL\nIL-12\nnaive\nCD8 T cell\nTH1\nIL-12 IFN-Y\nT-bet+\nType 2 ILC2, Th2, Eosino/Baso\nMHC II:\npeptide\nIL-7 TSLP\nILC2\n--\nTH2\nIL-13 IL-5\neosinophil\nID2+\nprecursor\nIL-33 IL-25\nGATA3+\nIL-4 IL-5 IL-13\nIL-4\nIL-4\nGATA3+\nnaive\nCD4 T cell\nHelminth chitin\nmast cell basophil\nType 3 ILC3, Th17, IgG1/2,Neut\nTGF-B\nIL-6\nILC3\n-A-\nTH17\nIL-7 IL-23 IL-1\nIL-17 IL-22\nIL-17 IL-22\nIL-1 IL-23\nRORγt\nAHR+\nneutrophil\nRORγt\nAHR+\nAnaphylactic shock: (2) IgE mediated hypersensitivity\n全身無防禦性過敏休克:為全身性的立即性過敏反應,是最嚴重的一種過敏反應。肥大細胞和嗜鹼性球釋放大量發炎介質至循環系統,造成血管擴張,血壓降低。絕大部分原因是藥物、毒素引起。病人常常來不及做出反應即休克、死亡。主要由 IgE 接上游離抗原產生,屬於 Type I hypersensitivity。\nType 1 hypersensitivity: (1) Involves mast cell, basophil, and eosinophil、(2) IgE mediated hypersensitivity、(3) Has immediate and late response\nType 1 hypersensitivity 為最常見的過敏反應,又稱為立即性過敏反應。在組織中,IgE 與肥大細胞(mast cell)的FcɛRI 結合並活化之造成過敏;在血液中則結合嗜鹼性球(basophil)的FcɛRI。另外也會結合嗜酸性球(eosinophil)的FcɛRII,但親和性較低。因此,肥大細胞、嗜鹼性球、嗜酸性球都會參與第一型過敏反應。另外,在過敏原暴露量較多的情況下,type 1 hypersensitivity 反應可分為兩階段-immediate and late response,前者發生於接觸過敏原數分鐘後,後者則發生在數小時後,因為肥大細胞需要重新合成顆粒中的發炎介質;常見的例子如 Wheal and flare response 即包含上述兩個階段。若過敏原暴露量不多,則只會有 immediate response.\nTuberculin test: (4) Type IV hypersensitivity\n第四型過敏反應是由T細胞引起的過敏反應,常見例子之一為皮膚結核菌素試驗(TST, tuberculin skin test)。將少量的結核菌成分 PPD 注射到皮下組織,如果受\n［出處］單元14",
    "original_number": 2
  }
]
